Your browser doesn't support javascript.
loading
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer.
Albino, Domenico; Falcione, Martina; Uboldi, Valeria; Temilola, Dada Oluwaseyi; Sandrini, Giada; Merulla, Jessica; Civenni, Gianluca; Kokanovic, Aleksandra; Stürchler, Alessandra; Shinde, Dheeraj; Garofalo, Mariangela; Mestre, Ricardo Pereira; Constâncio, Vera; Wium, Martha; Burrello, Jacopo; Baranzini, Nicolò; Grimaldi, Annalisa; Theurillat, Jean-Philippe; Bossi, Daniela; Barile, Lucio; Henrique, Rui M; Jeronimo, Carmen; Zerbini, Luiz Fernando; Catapano, Carlo V; Carbone, Giuseppina M.
Afiliação
  • Albino D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Falcione M; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Uboldi V; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Temilola DO; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Sandrini G; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Merulla J; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Civenni G; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Kokanovic A; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Stürchler A; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Shinde D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Garofalo M; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padova, Italy.
  • Mestre RP; Medical Oncology, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland.
  • Constâncio V; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Wium M; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Burrello J; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland.
  • Baranzini N; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy.
  • Grimaldi A; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy.
  • Theurillat JP; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Bossi D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.
  • Barile L; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland.
  • Henrique RM; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Jeronimo C; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Zerbini LF; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.
  • Catapano CV; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Carbone GM; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.
Commun Biol ; 4(1): 119, 2021 01 26.
Article em En | MEDLINE | ID: mdl-33500545
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Transformação Celular Neoplásica / MicroRNAs / Micropartículas Derivadas de Células / Vesículas Extracelulares Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Transformação Celular Neoplásica / MicroRNAs / Micropartículas Derivadas de Células / Vesículas Extracelulares Idioma: En Ano de publicação: 2021 Tipo de documento: Article